Ignite Creation Date:
2024-05-06 @ 8:51 AM
Last Modification Date:
2024-10-26 @ 12:06 PM
Study NCT ID:
NCT02834780
Status:
COMPLETED
Last Update Posted:
2023-11-13
First Post:
2016-07-13
Brief Title:
Phase 1 Study to Evaluate the Safety Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
Sponsor:
H3 Biomedicine Inc
Organization:
Eisai Inc
Organization Data
Organization:
Eisai Inc
Class:
INDUSTRY
Study ID:
H3B-6527-G000-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
H3 Biomedicine Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eisai Inc | INDUSTRY |